SEARCH

SEARCH BY CITATION

It took courage, persistence, and dogged research to persuade journals and indifferent academia that a major piece of cancer research was desperately flawed – even though it was guiding treatment in clinical trials. Darrel Ince tells the story, and finds that the Duke problem was not a one-off.